UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients

Investigational new drugs, 2021-08, Vol.39 (4), p.1189-1196

2021

Link zum Volltext

Verfügbarkeit prüfen

PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions

European journal of nuclear medicine and molecular imaging, 2021-11, Vol.48 (12), p.3975-3989

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy

European journal of nuclear medicine and molecular imaging, 2022-03, Vol.49 (4), p.1417-1428

2022

Link zum Volltext

Verfügbarkeit prüfen

Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate

Radiation oncology (London, England), 2022-03, Vol.17 (1), p.53-53, Article 53

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

European journal of nuclear medicine and molecular imaging, 2022-03, Vol.49 (4), p.1407-1416

2022

Link zum Volltext

Verfügbarkeit prüfen

In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer

Radiation oncology (London, England), 2020-11, Vol.15 (1), p.1-3, Article 252

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Radiation oncology (London, England), 2018-03, Vol.13 (1), p.37-9, Article 37

2018

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic cranial irradiation in resected early stage small cell lung cancer

International journal of radiation oncology, biology, physics, 2017-07, Vol.98 (3), p.612-614

2017

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting

Cancers, 2021-03, Vol.13 (7), p.1613

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Radiation oncology (London, England), 2020-07, Vol.15 (1), p.167-14, Article 167

2020

Link zum Volltext

Verfügbarkeit prüfen

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Investigational new drugs, 2022-02, Vol.40 (1), p.163-171

2022

Link zum Volltext

Verfügbarkeit prüfen

MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients

Radiation oncology (London, England), 2022-02, Vol.17 (1), p.43-43, Article 43

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Radiation oncology (London, England), 2020-01, Vol.15 (1), p.5-5, Article 5

2020

Link zum Volltext

Verfügbarkeit prüfen

MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience

Radiation oncology (London, England), 2022-01, Vol.17 (1), p.8-8, Article 8

2022

Link zum Volltext

Verfügbarkeit prüfen

Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study

Radiation oncology (London, England), 2023-04, Vol.18 (1), p.58-58, Article 58

2023

Link zum Volltext

Verfügbarkeit prüfen

Chemoprotective effects of Allium cepa and Allium sativum on lead acetate–mediated oxidative stress and dyslipidemia in Wistar rats

Comparative clinical pathology, 2021-02, Vol.30 (1), p.89-95

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis

Cancers, 2020-10, Vol.12 (10), p.3035

2020

Link zum Volltext

Verfügbarkeit prüfen

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer

Radiation oncology (London, England), 2020-06, Vol.15 (1), p.148-9, Article 148

2020

Link zum Volltext

Verfügbarkeit prüfen

Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5713

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy

Radiation oncology (London, England), 2017-11, Vol.12 (1), p.176-176, Article 176

2017

Link zum Volltext

Verfügbarkeit prüfen

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate

European journal of cancer (1990), 2018-05, Vol.95, p.109-111

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trial

Radiation oncology (London, England), 2023-06, Vol.18 (1), p.99-99, Article 99

2023

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial

Radiation oncology (London, England), 2023-05, Vol.18 (1), p.1-8, Article 74

2023

Link zum Volltext

Verfügbarkeit prüfen

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa

Frontiers in oncology, 2021-10, Vol.11, p.723536-723536

2021

Link zum Volltext

Verfügbarkeit prüfen

279 Durvalumab after chemoradiotherapy for PD-L1 expressing inoperable stage III NSCLC impacts local-regional control and overall survival

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A304-A304

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(132)

Publikationsform

Artikel
(131)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(84)
Science & Technology
(84)
Oncology
(57)
Humans
(41)
Lung Cancer
(38)
Radiation Therapy
(35)
Chemoradiotherapy
(29)
Radiology, Nuclear Medicine & Medical Imaging
(29)
Patients
(26)
Radiotherapy
(26)
Chemotherapy
(25)
Male
(23)
Non-Small Cell Lung Carcinoma
(20)
Female
(19)
Small Cell Lung Carcinoma
(19)
Care And Treatment
(18)
Survival
(18)
Medicine
(16)
Metastasis
(16)
Middle Aged
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients

PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy

Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Prophylactic cranial irradiation in resected early stage small cell lung cancer

Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients

Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience

Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study

Chemoprotective effects of Allium cepa and Allium sativum on lead acetate–mediated oxidative stress and dyslipidemia in Wistar rats

Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer

Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate

Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trial

Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa

279 Durvalumab after chemoradiotherapy for PD-L1 expressing inoperable stage III NSCLC impacts local-regional control and overall survival

Suchergebnisse filtern